HCU | HCU Network Australia

To be a driving force in the journey to a cure,
improving quality of life along the way.

Classical Homocystinuria (HCU) is a rare genetic disorder present from birth. In HCU, the body is unable to break down an amino acid called methionine. This causes a build up of methionine and another amino acid called homocysteine which affects the eyes, brain, bones and blood vessels and can cause serious health problems when untreated.

Learn more

Stay Informed with our eNews

HCU Updates

Experiences of diagnosis and patient satisfaction

A paper from the HCU Network Australia survey on the experiences of the homocystinuri…

Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria

Aeglea BioTherapeutics, Inc.has announced the U.S. Food and Drug Administration (FDA)…

Videos

View HCU YouTube Channel

Sponsors & Partners

HCU on Facebook

HCU Network Australia

Who we are

HCU Network Australia is a Health Promotion Charity established in 2014 with the vision “to be a driving force in the journey to a cure, improving quality of life along the way.” Our aim is to achieve meaningful progress and improved health outcomes for the HCU community through supporting the patient and their families, reducing the barriers to accurate diagnosis and foremost supporting and encouraging research for improved treatments options and ultimately a cure.

Hayley's Story

My name is Hayley and I am 17 years old. I have B6 non-responsive homocystinuria, which means I am constantly taking medication and must maintain a low-protein diet. Although this can be difficult at times, I am alive and well. Having HCU has not stopped me from doing many of the things that other 17…

Read full story

Ronnie and Charlotte's Story

Our family live in London, UK. Our children Ronnie 6 and Charlotte 3 were diagnosed in November 2013. Ronnie had been under medical investigation for worsening learning difficulties and physical deformities. He had been admitted to our local neuro unit for a brain scan, lumber puncture bloods and urine tests. The Lp had caused him…

Read full story

Xander and Max's Story

In the UK where we live screening for Homocystinuria has only recently been added to mandatory new born screening. Our sons Xander, aged 7, and Max, aged 5, were diagnosed with Homocystinuria in August 2013. At the time our younger son was taken to the Children’s Hospital for an emergency EEG as he was…

Read full story

Help us Fund Research for HCU

Thanks to our community of supporters we were able to make our first research grant in 2018. Help us continue these efforts.

Donate Now Read More

.swiper-slide img{max-width:100%;max-height:100%;}.swiper-slide{background:#fff;display:-webkit-box;display:-ms-flexbox;display:-webkit-flex;display:flex;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;-webkit-box-align:center;-ms-flex-align:center;-webkit-align-items:center;align-items:center;}.ls-v5 .ls-playvideo{background-image:url("https://nitrocdn.com/dmLYRjDAqCxfOoUDVrxuOpxWxQDCSrEu/assets/static/optimized/rev-75e4d47/wp-content/uploads/2016/11/play-icon.png") !important;background-position:0 0 !important;background-size:60px 60px !important;opacity:.5;}.ls-v5 .ls-playvideo.nitro-lazy{background-image:none !important;}

To be a driving force in the journey to a cure,
improving quality of life along the way.

HCU Updates

Experiences of diagnosis and patient satisfaction

Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria

Events

Videos

AccuGo for HCU

Sponsors & Partners

HCU on Facebook

Who we are